WP2: New versions of MedEye were released including Medication Service, which enables MedEye to work with different medication code systems and build a medication database. The user interface has been updated to improve the user friendliness and make sure all data management meets GDPR guidelines. Furthermore, the medication library is updated extensively including the connected EAN barcodes. The MedEye system has been integrated with multiple HIS systems, which number is constantly increasing. For the implementation in a UK hospital, the MedEye software had to be integrated into the local HIS. This turned out more difficult than anticipated resulting in the incorporation of JASEHealth to implement MedEye into the HIS at NUTH.
WP3: The pilot study at NUTH is performed. MedEye was implemented on one ward and data before and after were gathered. Ethical approval has been granted. Extensive testing was conducted at NUTH between Feb-July 2019. This involved testing of the user interface, medication mapping and integration. Issues were recorded and where possible resolved by the Hospital IT team, MINT and/or JASEHealth. The first nurses began testing MedEye in the Live Cerner environment in August 2019. The process of optimising the software has taken longer than originally anticipated. The rollout of the “Global Digital Exemplar (GDE)-progamme” of the NHS, has postponed the MedEye implementation. And the Covid-19 pandemic has limited the time we could survey on the ward. As a result the amount of gathered data was less than originally planned. But still sufficient to report good results.
WP4: Medeye was successfully implemented in 9 LTC facilities (69 devices). Baseline-measurements were performed to assess the medication and administration workflow at LTC facilities. More than 500 nurses were trained and added as users to the Medeye system and are now able to use Medeye in their day-to-day work. The pilot studies have been completed. Preliminary results indicate that MedEye improves identification and prevention of administration errors and that workflow efficiency with MedEye technology rapidly improves over time. Two psychiatric institutions have signed a contract with MedEye too. Rollout is from beginning of October 2019 onwards.
WP5: The commercialization strategy is constantly updated. After the successful implemention at Interzorg, the Medeye system has been implemented at a second LTC organization in NL: Present. With this implementation, MedEye is now integrated in the most widely spread medication management system in LTC organizations in NL. Because of the success of each LTC installation in NL and BE, MINT expects to be able to make concrete steps and expand the client portfolio within the next 12 months. A market research has been performed for EU-markets, Canada, USA and Australia. The market study results are submitted in deliverable D12. A commercialization strategy is worked out and submitted in deliverable D13. One of the results is an extensive business case calculator and comparator to competition for MedEye, based on own experience from pilots and installations, as well as research done in the area of barcode bedside verification.
WP6: Dissemination and communication activities are done on a diversity of platforms to reach all stakeholders (general public, end-users, decision makers, KOLs). Activities include (social) media coverage towards the general public (including an article in the NL national newspaper Telegraaf with reader coverage over 1 million), presentations at conferences, end-user trainings and a webinar. The dissemination and communication strategy is continuously updated. Activities are spreaded across the EU countries after the results of the pilot studies in BE and UK came available.
